Article
LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response.
Diabetes & metabolism - 1 Jun 2014
Chirico V, Ferraù V, Loddo I, Briuglia S, Amorini M, Salpietro V, Lacquaniti A, Salpietro C, Arrigo T
Abstract excerpt
AIM: This report highlights the metabolic, endocrine and cardiovascular comorbidities in a case of familial partial lipodystrophy (FPLD), and also evaluates the efficacy and safety of metformin therapy. METHODS: Mutational analysis was carried out of the LMNA gene in a teenage girl with an FPLD phenotype. Insulin resistance, sex hormones and metabolic parameters were also evaluated, and echocardiography,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
